Loading Events

« All Events

  • This event has passed.

Successfully Navigating The USPTO and FDA

September 8 @ 10:00 am - 2:00 pm

Best practices shared to help biotech/medtech startups navigate USPTO and FDA procedures.

About this event

Hear about the intricacies biotech/medtech independent inventors and startups face when securing Intellectual Property (IP) rights from the U.S. Patent and Trademark Office (USPTO) and/or seeking regulatory approval from the Food and Drug Administration (FDA). Government officials and industry professionals will join the discussion by offering their views on current hot topic issues while highlighting best practices to consider when filing with the USPTO or FDA.

Topics include:

  • Navigating the USPTO patent process, with an emphasis on biotech and medtech industries
  • Navigating the FDA regulatory process
  • Hot topics, strategies, tips, and best practices to maximize IP protection and exclusivity

Speakers:

  • Brandon Fetterolf, USPTO – Director (acting), TC 1600 Biotechnology and Organic Chemistry
  • Jonathan Teixeira Moffat, USPTO – Director, TC 3700 Medical Devices and Processes
  • Kevin Bugin, Ph.D., FDA – Deputy Director for Operations, CDER/Office of New Drugs
  • Barbara Zimmerman, FDA – Deputy Office Director, CDRH/Center for Devices and Radiological Health
  • Tom Cowan, Knobbe Martens – Partner
  • And more…

 

Register Now

*A meeting link will be sent to registered attendees the week of the event.

This event is in collaboration with the U.S. Patent and Trademark Office (USPTO), U.S. Food and Drug Administration (FDA) and Biocom California.

California MCLE credit will be offered.
Questions? Contact the Silicon Valley Regional USPTO via email siliconvalley@uspto.gov or call 408-918-9900.
To request a reasonable accommodation, including captioning, sign language interpreting, or other, please email siliconvalley@uspto.gov or call 408-918-9900.

 

*Not a BioNJ-hosted event.

Details

Date:
September 8
Time:
10:00 am - 2:00 pm
Event Category: